210 related articles for article (PubMed ID: 23648496)
1. [Osteonecrosis of the jaw associated with bisphosphonate therapy in primary osteoporosis. Review of the literature].
Outeiriño-Fernández A
An Sist Sanit Navar; 2013; 36(1):87-97. PubMed ID: 23648496
[TBL] [Abstract][Full Text] [Related]
2. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
3. Systematic literature review of bisphosphonates and osteonecrosis of the jaw in patients with osteoporosis.
Chamizo Carmona E; Gallego Flores A; Loza Santamaría E; Herrero Olea A; Rosario Lozano MP
Reumatol Clin; 2013; 9(3):172-7. PubMed ID: 22784630
[TBL] [Abstract][Full Text] [Related]
4. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
Giovannacci I; Meleti M; Manfredi M; Mortellaro C; Greco Lucchina A; Bonanini M; Vescovi P
J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
[TBL] [Abstract][Full Text] [Related]
5. Risk of Jaw Osteonecrosis After Intravenous Bisphosphonates in Cancer Patients and Patients Without Cancer.
Goodwin JS; Zhou J; Kuo YF; Baillargeon J
Mayo Clin Proc; 2017 Jan; 92(1):106-113. PubMed ID: 27876314
[TBL] [Abstract][Full Text] [Related]
6. What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review.
Aljohani S; Fliefel R; Ihbe J; Kühnisch J; Ehrenfeld M; Otto S
J Craniomaxillofac Surg; 2017 Sep; 45(9):1493-1502. PubMed ID: 28687467
[TBL] [Abstract][Full Text] [Related]
7. Frequency of osteonecrosis in bisphosphonate users submitted to dental procedures: A systematic review.
Martins LHI; Ferreira DC; Silva MT; Motta RHL; Franquez RT; Bergamaschi CC
Oral Dis; 2023 Jan; 29(1):75-99. PubMed ID: 34402147
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of bisphosphonates in root canal therapy.
AlRahabi MK; Ghabbani HM
Saudi Med J; 2018 Mar; 39(3):232-238. PubMed ID: 29543299
[TBL] [Abstract][Full Text] [Related]
9. Can children be affected by bisphosphonate-related osteonecrosis of the jaw? A systematic review.
Duarte NT; Rech BO; Martins IG; Franco JB; Ortega KL
Int J Oral Maxillofac Surg; 2020 Feb; 49(2):183-191. PubMed ID: 31447218
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate-induced osteonecrosis of the jaw.
Krueger CD; West PM; Sargent M; Lodolce AE; Pickard AS
Ann Pharmacother; 2007 Feb; 41(2):276-84. PubMed ID: 17299010
[TBL] [Abstract][Full Text] [Related]
11. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review.
Madrid C; Sanz M
Clin Oral Implants Res; 2009 Sep; 20 Suppl 4():87-95. PubMed ID: 19663954
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: Radiologic aspects.
Wasserzug O; Kaffe I; Lazarovici TS; Weissman T; Yahalom R; Fliss DM; Yarom N
Am J Rhinol Allergy; 2017 Jan; 31(1):36-39. PubMed ID: 28234151
[TBL] [Abstract][Full Text] [Related]
13. Impact of osteoporosis and its treatment on oral health.
Anil S; Preethanath RS; AlMoharib HS; Kamath KP; Anand PS
Am J Med Sci; 2013 Nov; 346(5):396-401. PubMed ID: 23588259
[TBL] [Abstract][Full Text] [Related]
14. Dental Implant Placement in Patients With a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review.
Sher J; Kirkham-Ali K; Luo JD; Miller C; Sharma D
J Oral Implantol; 2021 Jun; 47(3):249-268. PubMed ID: 32699903
[TBL] [Abstract][Full Text] [Related]
15. Use of bisphosphonates in older adults: how long is long enough?
Dunn RL; Bird ML; Conway SE; Stratton MA
Consult Pharm; 2013 Jan; 28(1):39-57. PubMed ID: 23315281
[TBL] [Abstract][Full Text] [Related]
16. [Osteonecrosis of the jaw].
Drozdzowska B
Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
[TBL] [Abstract][Full Text] [Related]
17. Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases.
Di Fede O; Fusco V; Matranga D; Solazzo L; Gabriele M; Gaeta GM; Favia G; Sprini D; Peluso F; Colella G; Vescovi P; Campisi G
Eur J Intern Med; 2013 Dec; 24(8):784-90. PubMed ID: 23768563
[TBL] [Abstract][Full Text] [Related]
18. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature.
Del Fabbro M; Gallesio G; Mozzati M
Eur J Cancer; 2015 Jan; 51(1):62-74. PubMed ID: 25466505
[TBL] [Abstract][Full Text] [Related]
19. [The rare case of osteonecrosis of the jaws in a patient treated with bisphosphonates for osteoporosis].
Lewandowski B; Brodowski R; Kość T; Migut M; Wojnar J
Przegl Lek; 2016; 73(1):46-8. PubMed ID: 27120948
[TBL] [Abstract][Full Text] [Related]
20. Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.
Bagan J; Peydró A; Calvo J; Leopoldo M; Jiménez Y; Bagan L
Oral Dis; 2016 May; 22(4):324-9. PubMed ID: 26818808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
